Day: October 14, 2020

Patriot One Releases Fourth Quarter and Year-end Results

TORONTO, Oct. 14, 2020 (GLOBE NEWSWIRE) — Patriot One Technologies Inc. (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), developer of the PATSCAN™ Multi-Sensor Threat Detection Platform, is pleased to announce its fourth quarter and annual financial results for the year ended July 31, 2020. All information is in Canadian dollars unless otherwise indicated.The following press release should be read in conjunction with the Company’s Annual Consolidated Financial Statements, prepared in accordance with International Financial Reporting Standards (“IFRS”) and our Management’s Discussion and Analysis for the years ended July 31, 2020 and July 31, 2019, which can be found on SEDAR at www.sedar.com and on the Company’s website at www.patriot1tech.com.“The key focus this year has been the de-risking the Company’s...

Continue reading

RedHill Biopharma 宣佈合作夥伴關係,以擴大 COVID-19 治療候選藥物 Opaganib 的生產

為準備申請緊急使用授權,RedHill Biopharma 與歐洲和加拿大供應商合作以擴大 opaganib 的生產規模,進一步提升製造能力和產能—      在 6 個國家 / 地區獲批後,使用 opaganib 治療 COVID-19 的全球第 2/3 期研究納入工作正在快速進行—使用 opaganib 治療 COVID-19 的美國第 2 期研究即將完成納入,且最近通過第二次獨立委員會審查以色列特拉維夫和北卡羅萊納州拉里格, Oct. 15, 2020 (GLOBE NEWSWIRE) — RedHill Biopharma Ltd. (Nasdaq: RDHL)(「RedHill 」或「公司」)是一家專門生物製藥公司,今天宣佈與歐洲和加拿大的兩家專業製藥公司合作,以加速生產 opaganib,從而支持緊急使用授權申請和後續需求,而使用該藥物治療嚴重 COVID-19 肺炎的全球第 2/3 期和美國第 2 期研究正在快速進展。RedHill 研發部高級副總裁 Reza Fathi 博士說:「鑑於使用 opaganib 治療 COVID-19 的第 2/3 期研究快速進展,我們現正與可信賴的優質合作夥伴擴大 opaganib 的製造能力和產能,以滿足獲得全球緊急使用授權後可能出現的需求。」Opaganib 是一種一流的口服鞘氨醇激酶-2 (SK2) 選擇性抑制劑,展示出抗炎及抗病毒活性雙重作用,可針對宿主細胞成分,有可能盡量降低病毒抗藥性的可能性。使用 opaganib 治療嚴重 COVID-19 肺炎患者的後期開發計劃包括:美國第 2 期研究 (NCT04414618) 正在於 8 個臨床試驗點持續進行,即將完成納入程序,且最近通過第二次獨立委員會審查,預計將在今年年底前發佈數據。此外,全球第 2/3 期研究 (NCT04467840),目前正在透過 15 個研究中心快速納入患者,並有望在今年年底前納入多達 270 名患者。這兩項研究都是隨機、雙盲、平行組、安慰劑對照試驗,讓需要住院和補充氧氣治療的嚴重...

Continue reading

RedHill Biopharma宣布合作伙伴关系以扩大新冠肺炎候选药物opaganib的制造规模

与欧洲和加拿大供应商就opaganib的大规模增产进行合作进一步加强制造能力和产能,为潜在的紧急用药申请获批做好准备—使用opaganib治疗新冠肺炎全球2/3期研究的患者招募在6个国家予以批准后迅速推进—在美国进行的opaganib治疗新冠肺炎2期研究即将完成患者招募,并于最近通过了独立委员会第二次审查以色列特拉维夫和北卡罗来纳罗利, Oct. 15, 2020 (GLOBE NEWSWIRE) — 特种生物制药企业RedHill Biopharma Ltd. (Nasdaq:RDHL)(以下称“RedHill”或“公司”)今天宣布与欧洲和加拿大的两家专业制药厂商合作以推进opaganib的生产。针对这种新药治疗重症新冠肺炎的全球范围2/3期研究和在美国进行的2期研究正在快速进行中。此次宣布的生产合作旨在支持潜在的紧急用途申请及随后的用药需求。“鉴于我们关于opagnib治疗新冠肺炎2/3期研究开发计划的快速推进,我们正在与倍受信赖的优质合作伙伴合作,扩大opaganib的制造能力和产能,以满足全球紧急用药申请一旦获批后的用药需求,”RedHill公司研发部高级副总裁Reza Fathi博士表示。Opaganib是一种首创的口服鞘氨醇激酶-2 (SK2) 选择性抑制剂,显示抗炎和抗病毒双重活性,靶向宿主细胞成分,因而有可能最大限度地降低耐药可能性。针对新冠肺炎重症患者的opaganib后期开发项目包括:美国2期研究(NCT04414618),目前正在八个临床试验中心进行,患者招募已接近完成,并在最近通过了独立委员会的第二次审查,预计数据将在今年年底前公布;全球2/3期研究(NCT04467840),正在15个研究地点迅速开展患者招募,有望在年底前招募270名患者。两项研究均为将opaganib用于需住院治疗和辅助供氧的新冠肺炎重症患者的随机、双盲、平行、安慰剂对照型试验。Opaganib表现出对导致新冠病毒的有效抗病毒活性,在人体肺支气管组织的体外模型中完全抑制病毒复制。该公司正在与美国政府机构就可能提供的资金进行讨论,以支持opaganib作为紧急用药的潜在申请以及扩大生产规模方面取得的迅速进展。关于Opaganib(ABC294640,Yeliva®)Opaganib作为一种新型化学实体,是专有、首创口服鞘氨醇激酶-2...

Continue reading

Clean TeQ Holdings Limited Annual General Meeting

MELBOURNE, Australia, Oct. 14, 2020 (GLOBE NEWSWIRE) — Clean TeQ Holdings Limited (‘Clean TeQ’ or ‘Company’) (ASX/TSX:CLQ; OTCQX:CTEQF) will today at 12 noon (AEST) hold its 2020 Annual General Meeting via webcast. Shareholders and guests are able to register and attend the AGM by accessing the weblink below up to one hour prior to the commencement of the meeting:https://web.lumiagm.com/307096519Managing Director and CEO, Mr Sam Riggall, will provide a general update at the AGM. Mr Riggall’s presentation is attached.This announcement is authorised for release to the market by the Board of Directors of Clean TeQ Holdings Limited.About Clean TeQ Holdings Limited (ASX/TSX: CLQ) – Based in Melbourne, Australia, Clean TeQ is a global leader in metals recovery and industrial water treatment through the application of its proprietary Clean-iX®...

Continue reading

Clean TeQ Announces Drilling Commences to Test Large Platinum Resource at Depth

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/9c738696-49e4-457a-a716-75add7f40005Highlights:A drill rig mobilised to Sunrise Project site has commenced a six-hole diamond core drill program. The program is aiming to intersect the dunite structures at depth (targeting 400-600m below surface) which are proposed to be the source of the platinum in the Sunrise laterite at surface.The Sunrise laterite hosts a significant platinum resource1 of 103.1 Mt @ 0.33 g/t Pt for 1,076,170 ounces of platinum, using a 0.15 g/t Pt cut-off grade, making it one of the largest platinum resources in Australia. Of this total resource, approximately 90% (metal content) is in the measured and indicated categories. While the average grade over the global resource is relatively low, areas of significantly...

Continue reading

REC Silicon – Key information relating to subsequent offering to be carried out by REC Silicon ASA

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.Lysaker, 14 October 2020 – Reference is made to the stock exchange notice from REC Silicon ASA (the “Company”) on 14 October 2020 regarding the successful completion of a private placement of 92,592,592 new shares in the Company (the “Private Placement”) and a potential subsequent offering at the same subscription price as in the Private Placement (the “Subsequent Offering”).Other information: The Subsequent Offering is subject to (a) completion of the Private Placement, (b) approval of the authorization of the Board of Directors for the Subsequent Offering by the...

Continue reading

Array Technologies, Inc. Announces Pricing of Upsized Initial Public Offering

ALBUQUERQUE, N.M., Oct. 14, 2020 (GLOBE NEWSWIRE) — Array Technologies, Inc. (the “Company”) today announced the pricing of its upsized initial public offering of 47,500,000 shares of its common stock at a price to the public of $22.00 per share. The offering consists of 7,000,000 shares of common stock being sold by the Company and 40,500,000 shares of common stock being sold by a parent entity of the Company controlled by Oaktree Capital (the “Selling Stockholder”). In addition, the Selling Stockholder granted the underwriters a 30-day option to purchase up to an additional 7,125,000 shares at the public offering price, less underwriting discounts and commissions. The Company will not receive any proceeds from any sale of shares by the Selling Stockholder. The shares of common stock are expected to begin trading on the Nasdaq...

Continue reading

Gold Resource Reports Preliminary Q3 Production Results Including Record Gold Production and 51% Nevada Gold Production Increase

COLORADO SPRINGS, Oct. 14, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Gold Resource Corporation (NYSE American: GORO) (the “Company”) reports preliminary consolidated record gold production results for the third quarter ended September 30, 2020 of 12,575 gold ounces, 333,761 silver ounces and significant base metals.  Nevada gold production increased by 51% as the production ramp up phase continues.  Gold Resource Corporation is a gold and silver producer, developer and explorer with operations in Oaxaca, Mexico and Nevada, USA.  The Company has returned $115 million to its shareholders in consecutive monthly dividends since July 2010 and offers its shareholders the option to convert their cash dividends into physical gold and silver and take delivery. Preliminary record third quarter production from the Company’s Nevada Mining...

Continue reading

Mercer Park Brand Acquisition Corp. Announces Election of Directors

TORONTO, Oct. 14, 2020 (GLOBE NEWSWIRE) — MERCER PARK BRAND ACQUISITION CORP. (“Mercer” or the “Company”) announced that the nominees listed in the management information circular and proxy statement for the 2020 annual general meeting of Class B shareholders were elected as directors of the Company. Detailed results of the votes by proxy for the election of directors held virtually today in Toronto, Ontario are set out below.Details of the voting results on all matters considered at the meeting are available in the Company’s report of voting results, which is available under the Company’s profile on SEDAR at www.sedar.com.About Mercer Park Brand Acquisition Corp.Mercer Park Brand is a special purpose acquisition corporation incorporated under the laws of the Province of British Columbia for the purpose of effecting a Qualifying Transaction.FOR...

Continue reading

REC Silicon – Private placement successfully completed

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.Lysaker, 14 October 2020.Reference is made to the stock exchange release from REC Silicon ASA (“REC” or the “Company”) published on 14 October 2020 regarding a contemplated private placement (the “Private Placement”). The Company is pleased to announce that it has raised approximately NOK 1,000 million in gross proceeds through the Private Placement of 92,592,592 new shares (the “New Shares”), at a price per share of NOK 10.80 (the “Offer Price”). The Private Placement took place through a process managed by Arctic Securities AS and Pareto Securities...

Continue reading